| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.9M | $9.1M | $16.0M |
| YoY Revenue Growth % | -68.6% | -43.0% | — |
| Gross Profit | -$1.8M | $5.1M | — |
| Gross Margin % | -50.0% | 55.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$36.5M | -$13.1M | -$14.6M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$43.4M | -$12.4M | -$22.5M |
| EBITDA (Normalized) | -$34.6M | -$12.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$30.7M | -$31.0M | -$8.8M |
| Capital Expenditures (CapEx) | $2.4M | $542.0K | — |
| Free Cash Flow (FCF) | -$33.1M | -$31.5M | -$8.8M |
| FCF Margin % | -80.0% | -80.0% | -55.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $590.0K | $1.4M | — |
| Total Debt (Short + Long Term) | $6.0M | $4.9M | — |
| Total Stockholders' Equity | -$83.3M | -$59.3M | — |